DNA may predict risk of catching common cold
By Ayshe Ismail, 20 February 2013
People with shorter DNA 'caps' on the ends of their chromosomes are more likely to develop a respiratory infection from the cold virus, research suggests.
A study investigating susceptibility to the common cold found people with shorter tips on their chromosomes - called telomeres - in white blood cells were more likely to develop symptoms.
Researchers now hope to use telomere length to predict those who may be at risk of certain diseases.
Telomeres are sections of DNA on the ends of chromosomes that shrink as the cell ages. Shorter telomeres have already been linked to a greater risk of cardiovascular disease, cancer and premature death. Yet their role in the health of younger adults remains unclear.
To investigate this, researchers assessed telomere length in four types of blood cells, including leukocytes, in 152 healthy adult patients aged 18 to 55 years.
Participants were then administered nasal drops containing rhinovirus 39 - the common cold virus - and monitored for the development of clinical illness and infection.
A total of 69% of 105 participants developed an infection and 22% developed the common cold. Shorter telomere lengths in all four cell types were associated with greater odds of developing infection from age 22, following exposure to the cold virus.
The telomere length of one type of immune cell, called CD8CD28- cells, had the greatest association with infection and was the only cell type associated with the development of clinical illness.
Professor Sheldon Cohen, lead author of the study, explains the findings
Lead author Professor Sheldon Cohen from Carnegie Mellon University in Pittsburgh, Pennsylvania said: 'These cells are important in eliminating infected cells and those with shorter telomeres in the CD8CD28- cell population may be at greater risk for infection because they have fewer functional cells available to respond to the [cold] virus.'
He added: 'Our work suggests the possibility that telomere length is a relatively consistent marker across the life span and that it can start predicting disease susceptibility in young adulthood.'
- Related Drug Categories
- Viral infections
- Related MIMS Tables
- Routine Childhood Immunisation Schedule
- Summary of Antibiotic Treatments in Adults
- Related MIMS Guidelines and Summaries
- Peginterferon Alfa and Ribavirin for Treating Chronic Hepatitis C in Children and Young People (TA300)
- Colistimethate Sodium and Tobramycin Dry Powders for Inhalation for Treating Pseudomonas Lung Infection in Cystic Fibrosis (TA276)
- Boceprevir for the Treatment of Genotype 1 Chronic Hepatitis C (TA253)
Latest jobs Jobs web feed
- Clinical Research Physician Synexus Ltd Competitive, UK based sites
- Salaried GP DMC Healthcare Competitive Salary, East Dulwich, South London
- Salaried GP The Medical Centre - Kent Competitive, Maidstone, Kent
- Salaried GP Horden Group Practice Salary will be dependant on experience, Horden, County Durham
- Locum GP - Derbyshire and surrounding areas. Angel Human Resources LLP Excellent rates of pay and travel contributions paid to the Locum GP, Various choices of work offered to the Locum GP In Derbyshire areas and surrounding areas
- Locum GP - Cumbria and surrounding areas. Angel Human Resources LLP Excellent rates of pay and travel contributions paid to the Locum GP, Various choices of work offered to the Locum GP In Cumbria areas and surrounding areas